Article Details
Retrieved on: 2024-08-06 14:21:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
With a 51.0% market share, the monoclonal antibodies segment is estimated to dominate the market in 2024. Competitive Landscape: The ...
Article found on: www.digitaljournal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here